Close

Fireside Chat Speakers, Programming Announced for 2017 BIO Investor Forum

Aug 15 2017
BIO announces programming for the upcoming BIO Investor Conference Oct. 17-18 in San Francisco including Kristina Burow, Managing Director of ARCH Venture Partners and Dr. Richard Scheller, Chief Science Officer & Head of Therapeutics for 23andMe. The annual conference explores global investment trends and opportunities in life sciences. Early and mid-stage private as well as emerging public companies poised for growth in 2018 are the focus of the event.  

BIO: Senate Passage of FDA User Fee Package Important Victory for Patients, Medical Innovation

Aug 3 2017
Washington, DC (August 3, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement regarding passage of the Food and Drug Administration Reauthorization Act (FDARA) by the U.S. Senate today:

BIO Applauds US Court of Appeals Decision on the Renewable Fuel Standard

Jul 28 2017
The U.S. Court of Appeals for the District of Columbia Circuit today supported BIO's argument that the RFS statute does not allow EPA to rely on demand-side factors under the oil industry’s control as a basis for setting annual renewable fuel volumes.

The 2017 BIO World Congress Comes to a Close in Montreal

Jul 26 2017
The 14th annual BIO World Congress drew 954 attendees. The world’s largest industrial biotechnology event hosted more than 227 speakers in seven education tracks and five plenaries and set a new conference record for partnering meetings.

Democrats' Plan on Drug Costs a “Bad Deal for Patients and the Future of American Innovation”

Jul 24 2017
Plan will restrict seniors’ access to prescription drugs and undermine quest for biopharmaceutical innovations and cures Washington, DC (July 24, 2017) – Biotechnology Innovation Organization (BIO) Director of Communications Brian Newell released the following statement regarding the drug cost plan released today by Congressional Democrats:

Gord Surgeoner to Receive 2017 BIO Leadership and Legacy Award

Jul 18 2017
Dr. Gord Surgeoner, OOnt, former president of Ontario Agri-Food Technologies (OAFT), will receive the 2nd annual BIO Leadership and Legacy Award on Wednesday July 26, 2017, during a lunch plenary session of the 2017 BIO World Congress on Industrial Biotechnology.

BIO Statement on the Status of the U.S.-China 100-Day Plan

Jul 17 2017
Washington, D.C. (July 17, 2017) – The Biotechnology Innovation Organization (BIO) today issued the following statement on the status of the U.S.-China 100-day plan:

Rhode Island Governor Gina Raimondo Presented 2017 BIO Governor of the Year Award

Jul 14 2017
BIO today presented Rhode Island Governor Gina Raimondo with its 2017 Governor of the Year award in recognition of her leadership and commitment to strengthening the bioscience industry within Rhode Island. Governor Raimondo received the award at the National Governor’s Association Summer Meeting, held at the Providence Convention Center.

BIO Applauds House Passage of Food and Drug Administration Reauthorization Act (FDARA)

Jul 12 2017
Urges swift Senate vote to ensure continuity of critical FDA functions   Washington, DC (July 12, 2017) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the Food and Drug Administration Reauthorization Act (FDARA) by the U.S. House of Representatives:

BIO Statement on EPA’s Proposed 2018 Renewable Fuel Standards

Jul 5 2017
Washington, D.C. (July 5, 2017) – The Environmental Protection Agency’s proposed Renewable Fuel Standards for 2018 and biomass-based diesel volume for 2019 must be improved to support investment and capacity building for advanced and cellulosic biofuels, the Biotechnology Innovation Organization (BIO) said today.